180 related articles for article (PubMed ID: 17764468)
21. [Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].
Li TY; Xue YQ; Wu YF; Pan JL; Liu DD; Gong SL
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):732-5. PubMed ID: 15200909
[TBL] [Abstract][Full Text] [Related]
22. Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-).
Li T; Xue Y; Wu Y; Pan J
Br J Haematol; 2004 May; 125(3):337-42. PubMed ID: 15086414
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
[TBL] [Abstract][Full Text] [Related]
24. Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients.
Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
Leuk Res; 2009 Sep; 33(9):1194-8. PubMed ID: 19128829
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
Wang L; Fidler C; Nadig N; Giagounidis A; Della Porta MG; Malcovati L; Killick S; Gattermann N; Aul C; Boultwood J; Wainscoat JS
Haematologica; 2008 Jul; 93(7):994-1000. PubMed ID: 18508791
[TBL] [Abstract][Full Text] [Related]
26. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary alveolar proteinosis as a terminal complication in a case of myelodysplastic syndrome with idic(20q-).
Xue Y; Han Y; Li T; Chen S; Zhang J; Pan J; Wu Y; Wang Y; Shen J
Acta Haematol; 2010; 123(1):55-8. PubMed ID: 19955712
[TBL] [Abstract][Full Text] [Related]
28. Atypical cytogenetics in therapy-related myelodysplastic syndrome secondary to indolent B-cell lymphoma.
Sinsabaugh C
Clin Lab Sci; 2011; 24(3):142-6. PubMed ID: 21905579
[TBL] [Abstract][Full Text] [Related]
29. Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation.
Thomas-Kaskel AK; Mattern D; Köhler G; Finke J; Behringer D
Cytometry B Clin Cytom; 2007 Jul; 72(4):241-8. PubMed ID: 17266149
[TBL] [Abstract][Full Text] [Related]
30. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
[TBL] [Abstract][Full Text] [Related]
31. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
Slovak ML; O'Donnell M; Smith DD; Gaal K
Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
[TBL] [Abstract][Full Text] [Related]
32. The characteristics and prognostic analysis in 213 myeloid malignancy patients with del(20q): a report of a single-center case series.
Pan J; Wu C; Xue Y; Qiu H; Chen S; Zhang J; Bai S; Wu Y; Wang Y; Shen J; Gong Y
Cancer Genet; 2014 Mar; 207(3):51-6. PubMed ID: 24699042
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and experimental study of two cases of myelodysplastic syndromes with double isochromosome 20q- anomaly].
Gong SL; Xue YQ; Wang JM; Han FL; Xu YQ; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):35-8. PubMed ID: 15946507
[TBL] [Abstract][Full Text] [Related]
34. Myelodysplastic syndrome of del 20q with plasma cell dysplasia.
Saito N; Higashiura K; Ehata K; Kurosawa S; Honma K; Abe M; Kimura A; Suzuki M; Nakamura S; Shiku H; Kean Ooi H
J Clin Exp Hematop; 2011; 51(2):141-5. PubMed ID: 22104314
[TBL] [Abstract][Full Text] [Related]
35. Refractory thrombocytopenia. A myelodysplastic syndrome that may mimic immune thrombocytopenic purpura.
Menke DM; Colon-Otero G; Cockerill KJ; Jenkins RB; Noel P; Pierre RV
Am J Clin Pathol; 1992 Nov; 98(5):502-10. PubMed ID: 1485603
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome.
Douet-Guilbert N; Laï JL; Basinko A; Gueganic N; Andrieux J; Pollet B; Plantier I; Delattre C; Crépin O; Corm S; Le Bris MJ; Morel F; De Braekeleer M
Br J Haematol; 2008 Dec; 143(5):716-20. PubMed ID: 19036015
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and laboratory features of 13 cases of myeloid neoplasms with double del (20q)].
Bai S; Wu C; Zhang J; Chen S; Pan J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):546-549. PubMed ID: 28777856
[TBL] [Abstract][Full Text] [Related]
38. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Swolin B; Rödjer S; Westin J
Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
[TBL] [Abstract][Full Text] [Related]
39. Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.
Haferlach C; Bacher U; Tiu R; Maciejewski JP; List A
Cancer Genet Cytogenet; 2008 Dec; 187(2):101-11. PubMed ID: 19027491
[TBL] [Abstract][Full Text] [Related]
40. Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura.
Ntaios G; Papadopoulos A; Chatzinikolaou A; Saouli Z; Karalazou P; Kaiafa G; Girtovitis F; Kontoninas Z; Savopoulos C; Hatzitolios A; Alexiou-Daniel S
Acta Haematol; 2008; 119(3):173-7. PubMed ID: 18511864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
